(IBTL) iShares iBonds Dec 2031 - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E4605 • Target Maturity
IBTL: U.S. Treasury, Bonds, Securities
The iShares iBonds Dec 2031 Term Treasury ETF (NASDAQ:IBTL) is designed to provide exposure to U.S. Treasury securities with maturities in late 2031. The fund tracks an index of publicly-issued Treasury bonds maturing between January 1, 2031, and December 15, 2031. It maintains at least 80% of its assets in these securities, ensuring alignment with its target maturity strategy.
As of the latest data, IBTL has an average 20-day volume of 77,262 shares and a last price of $20.28. Its short-term SMA (20-period) is $19.95, while the SMA 50 and SMA 200 are $19.80 and $19.78, respectively. The ATR is 0.08, indicating low volatility. The fund manages assets of $293.31 million, reflecting its role as a targeted maturity Treasury ETF.
3-Month Forecast: Based on the SMA trends and ATR, IBTL is expected to trade within a narrow range, with potential upside limited by its target maturity. The funds price may stabilize near current levels, with minimal volatility due to its low ATR.
Additional Sources for IBTL ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBTL ETF Overview
| Market Cap in USD | 300m |
| Category | Target Maturity |
| TER | 0.07% |
| IPO / Inception | 2021-07-13 |
IBTL ETF Ratings
| Growth 5y | -6.22% |
| Fundamental | - |
| Dividend | 73.2% |
| Rel. Strength Industry | -2 |
| Analysts | - |
| Fair Price Momentum | 19.46 USD |
| Fair Price DCF | - |
IBTL Dividends
| Dividend Yield 12m | 4.12% |
| Yield on Cost 5y | 3.62% |
| Annual Growth 5y | 49.71% |
| Payout Consistency | 100.0% |
IBTL Growth Ratios
| Growth Correlation 3m | 68.2% |
| Growth Correlation 12m | 62.7% |
| Growth Correlation 5y | -34.5% |
| CAGR 5y | -3.17% |
| CAGR/Max DD 5y | -0.15 |
| Sharpe Ratio 12m | 0.36 |
| Alpha | 0.34 |
| Beta | 0.08 |
| Volatility | 5.03% |
| Current Volume | 70.7k |
| Average Volume 20d | 71.1k |
As of March 14, 2025, the stock is trading at USD 20.21 with a total of 70,668 shares traded.
Over the past week, the price has changed by +0.28%, over one month by +2.24%, over three months by +2.11% and over the past year by +4.87%.
Neither. Based on ValueRay Analyses, iShares iBonds Dec 2031 is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -6.22 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBTL as of March 2025 is 19.46. This means that IBTL is currently overvalued and has a potential downside of -3.71%.
iShares iBonds Dec 2031 has no consensus analysts rating.
According to ValueRays Forecast Model, IBTL iShares iBonds Dec 2031 will be worth about 21 in March 2026. The stock is currently trading at 20.21. This means that the stock has a potential upside of +3.96%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 21 | 4% |